Marijuana rescheduling is one of those headlines that sounds simple until you ask the obvious question:
So... is marijuana federally legal now?
No.
But something important did happen in 2026.
As of August 13, 2026, FDA-approved marijuana products and marijuana covered by qualifying state medical marijuana licenses have been moved to Schedule III. Broader marijuana, including adult-use marijuana, has not yet been fully rescheduled and generally remains Schedule I while a separate federal rulemaking continues.
That's a much more significant development than simply saying rescheduling is "being considered."
Here's what actually changed.
Key Takeaways
- On April 28, 2026, certain medical marijuana moved to Schedule III. The rule covers FDA-approved marijuana products and marijuana subject to qualifying state medical marijuana licenses.
- Adult-use marijuana did not become federally legal. Marijuana outside the medical categories covered by the April rule generally remains Schedule I.
- A separate proceeding to move marijuana more broadly from Schedule I to Schedule III is still underway.
- DEA's hearing on broader rescheduling ran from June 29 through July 15, 2026. Post-hearing briefs are due August 17.
- State medical marijuana businesses gained potentially significant federal tax relief because Section 280E applies to Schedule I and II controlled substances, not Schedule III.
- Rescheduling does not automatically eliminate drug testing. DOT continues to treat marijuana positives as positive even when someone used marijuana through a state medical program.
- Hemp-derived THC remains a separate legal category, with major federal hemp changes currently scheduled for November 12, 2026.
This article is for general informational purposes only and does not constitute legal, tax, employment, or medical advice. Cannabis laws and regulations are changing rapidly.
What Does Marijuana Rescheduling Mean?
Rescheduling changes marijuana's classification under the federal Controlled Substances Act. It does not automatically legalize marijuana nationwide.
The Controlled Substances Act divides controlled drugs into five schedules.
Schedule I is the most restrictive category and applies to substances considered under federal law to have no currently accepted medical use and a high potential for abuse.
Schedule III substances are still controlled, but federal law recognizes an accepted medical use and considers their abuse potential lower than Schedule I or II substances.
In 2023, the Department of Health and Human Services recommended moving marijuana to Schedule III after concluding that marijuana has a currently accepted medical use and a lower abuse potential than substances in Schedules I and II.
That recommendation eventually led to something concrete in 2026.
What Marijuana Actually Became Schedule III in 2026?
The April 28, 2026 rule did not move all marijuana to Schedule III. It moved specific medical marijuana categories.
The final rule applies to:
- FDA-approved drug products containing marijuana
- Marijuana subject to qualifying state medical marijuana licenses
- Certain marijuana extracts and plant-derived delta-9 THC falling within those medical categories
The rule became effective April 28, 2026.
That is a substantial change.
DEA even launched a registration process for state-licensed medical marijuana dispensaries and other qualifying businesses operating under the new framework.
But the distinction between medical and adult-use marijuana matters enormously.
Is Marijuana Federally Legal Now?
No. Schedule III is not the same thing as federal legalization.
Schedule III substances are still controlled substances.
More importantly, marijuana outside the categories covered by the April 2026 medical rule generally remains Schedule I while broader rescheduling is still being considered.
That means an adult-use dispensary operating legally under state law should not assume that the April rule suddenly made its recreational marijuana federally legal.
The federal and state systems are still not fully aligned.
What Is Happening With Broader Marijuana Rescheduling?
DEA is still considering whether marijuana more broadly should move from Schedule I to Schedule III.
The federal government originally proposed broader Schedule III rescheduling in May 2024.
President Trump then issued Executive Order 14370 on December 18, 2025, directing the Attorney General to complete the rescheduling process as quickly as federal law allows.
DEA restarted formal hearings in June 2026.
Those proceedings ran from June 29 through July 15, 2026.
And this is where things stand today.
As of August 13, 2026
The hearing is finished.
But the process is not.
DEA's Chief Administrative Law Judge gave participating parties until August 17, 2026 to submit transcript corrections and post-hearing briefs containing their closing arguments and proposed findings.
So anyone claiming that broader federal marijuana rescheduling is already finished is getting ahead of the process.
There is not yet a final broader Schedule III rule in effect.
What Changed for Medical Marijuana Businesses?
One of the biggest immediate consequences isn't something consumers see on a dispensary shelf.
It's taxes.
Section 280E
The April 2026 rule states that qualifying state medical marijuana licensees are no longer subject to Internal Revenue Code Section 280E solely because of marijuana's scheduling.
Section 280E prevents businesses trafficking in Schedule I or II controlled substances from taking many ordinary business deductions.
Schedule III falls outside that restriction.
The April rule specifically identifies relief from 280E as a consequence of the rescheduling of state-licensed medical marijuana.
For medical cannabis businesses, that could be financially significant.
Adult-use operations are a different issue because recreational marijuana generally remains Schedule I under the current framework.
Businesses operating in both medical and recreational markets should get specialized tax and legal advice rather than assuming the entire company automatically qualifies.
Does Rescheduling Change Marijuana Drug Testing?
Not automatically.
A drug test measures THC or THC metabolites. Changing marijuana's federal schedule does not change the chemistry of the test.
And some regulated programs have explicitly kept their existing rules.
The Department of Transportation clarified in May 2026 that a positive marijuana test cannot currently be changed to a negative simply because the employee used marijuana through a state medical marijuana program.
DOT still requires testing for marijuana in safety-sensitive transportation jobs.
Federal workplace testing panels also currently continue to include marijuana, including urine testing for the THC metabolite Δ9THCC.
Private employers can have their own policies, subject to applicable state and local laws.
So if your job depends on passing a drug test, don't interpret "Schedule III" as "drug testing no longer matters."
Our Will Hemp-Derived THC Gummies Make Me Fail a Drug Test? guide goes deeper into how THC testing actually works.
Can You Travel More Freely With Marijuana Now?
Rescheduling does not create a blanket federal right to carry marijuana anywhere you want.
This is another area where headlines can be misleading.
Medical marijuana, adult-use marijuana and hemp-derived THC can fall under different federal and state rules.
Where you're leaving, where you're going, what product you're carrying and which laws apply can all matter.
In other words:
Schedule III is not a nationwide travel pass for cannabis.
What Does Marijuana Rescheduling Mean for Hemp-Derived THC?
Very little directly. Hemp and marijuana operate under separate federal legal definitions.
That's especially important for CBDX customers.
CBDX products are built around hemp-derived cannabinoids, not state-licensed marijuana.
The April 2026 marijuana rescheduling rule explicitly says it does not change the federal status of hemp because qualifying hemp is excluded from the Controlled Substances Act's definition of marijuana.
But hemp has its own major change approaching.
The Bigger Date for Hemp Is November 12, 2026
Current federal law dramatically narrows the definition of legal hemp beginning November 12, 2026.
Among other provisions, the new definition excludes certain finished hemp-derived cannabinoid products containing more than 0.4 milligrams combined total THC and similar cannabinoids per container.
Under current law, hemp products that meet the existing 2018 Farm Bill definition remain outside federal controlled-substance status through November 11, 2026. The amended definition takes effect the following day.
That change is legally separate from marijuana rescheduling.
Interestingly, President Trump's December 2025 executive order also directed the administration to work with Congress on the definition and regulation of finished hemp-derived cannabinoid products.
So both sides of federal cannabis policy are moving at once:
Marijuana is moving toward potentially broader Schedule III treatment.
Hemp-derived cannabinoids are facing a significantly narrower federal definition.
For CBDX and the wider hemp industry, that second issue may ultimately matter even more.
Does Rescheduling Mean You Can Buy Marijuana Online Nationwide?
No.
Broader marijuana rescheduling would not automatically create a nationwide direct-to-consumer marijuana market.
State cannabis licensing, federal controlled-substance requirements, FDA rules and other laws still matter.
Hemp-derived products are a separate category, and their legality also depends on federal requirements and increasingly restrictive state laws.
The phrase "THC is legal now" is simply too broad to be useful in 2026.
You have to ask:
Which THC? From hemp or marijuana? Medical or recreational? In which state? And under which law?
What Should Consumers Actually Watch Next?
Forget the endless predictions.
Four developments matter most.
1. What Happens After August 17
Post-hearing briefs in the broader DEA rescheduling case are due August 17, 2026.
That moves the proceeding closer to an administrative recommendation and eventual agency action.
2. A Final Broader Rescheduling Decision
Until a final rule is issued and becomes effective, marijuana outside the April medical framework generally remains Schedule I.
That's the headline worth watching.
3. How States Respond
Federal rescheduling does not erase state cannabis law.
States will continue making their own decisions about possession, medical programs, adult-use sales, employment protections and product regulation.
4. The November 12 Hemp Deadline
For hemp-derived THC consumers and companies, the scheduled federal hemp-law change may have a more immediate practical impact than marijuana rescheduling itself.
Frequently Asked Questions
Did marijuana become Schedule III in 2026?
Some marijuana did.
Effective April 28, 2026, FDA-approved marijuana products and marijuana subject to qualifying state medical marijuana licenses moved to Schedule III. Broader marijuana rescheduling remains unfinished.
Is recreational marijuana federally legal now?
No. Adult-use marijuana has not been federally legalized, and marijuana outside the medical categories covered by the April rule generally remains Schedule I.
When will broader marijuana rescheduling be finished?
There is currently no confirmed effective date.
The DEA hearing concluded July 15, 2026, and post-hearing briefs are due August 17. Further administrative action must follow.
Does Schedule III stop workplace drug testing?
No automatic change eliminates THC testing.
DOT currently continues marijuana testing and does not treat state medical marijuana use as a legitimate medical explanation for a positive result.
Does marijuana rescheduling change hemp-derived THC laws?
Not directly.
Hemp is governed under a separate statutory definition. That definition is currently scheduled to change on November 12, 2026.
Will Schedule III help marijuana businesses?
For qualifying medical marijuana businesses, yes in at least one significant area: the April rule states that state medical licensees are no longer subject to Section 280E because that tax restriction applies to Schedule I and II substances.
The Bottom Line
The marijuana rescheduling story in 2026 isn't simply:
"Marijuana is becoming Schedule III."
The reality is more interesting.
Medical marijuana took a major step toward federal recognition in April 2026. Adult-use marijuana remains federally restricted. Broader rescheduling is still moving through DEA. And hemp-derived THC is heading toward an entirely separate regulatory turning point in November.
For consumers, that means the old shortcuts no longer work.
"Legal cannabis," "medical marijuana," "hemp THC," and "Schedule III" are not interchangeable terms.
Know which category you're dealing with.
Then watch what happens next.
